Oryzon Genomics Market Cap

Oryzon Genomics has a market cap or net worth of $243.07 million as of June 20, 2025. Its market cap has increased by 89.73% in one year.

Market Cap

243.07M

Enterprise Value

255.28M

Revenue

7.95M

Ranking

n/a

PE Ratio

n/a

Stock Price

$3.22

Market Cap Chart

Since December 14, 2015, Oryzon Genomics's market cap has increased from 134.67M to 243.07M, an increase of 80.50%. That is a compound annual growth rate of 6.40%.

Market Cap History

Date	Market Cap	% Change
Jun 20, 2025	243.07M	159.15%
Dec 31, 2024	93.79M	-21.99%
Dec 29, 2023	120.23M	-15.47%
Dec 30, 2022	142.23M	-11.82%
Dec 30, 2021	161.30M	-37.25%
Dec 31, 2020	257.03M	81.12%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.62B
Veradigm	747.25M
Elite Pharmaceuticals	715.74M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	637.25M
CytoDyn	425.33M
American Oncology Network	408.69M
Glass House Brands	405.91M

Market Cap Rankings